-
Bayer Intellectual Property GmbH, et al v. Aurobindo Pharma Limited, et al DC CAFC
- 1:15-cv-00902
- D. Del.
- Judge: Richard G. Andrews
- Filed: 10/09/2015
- Closed: 07/13/2018
- Latest Docket Entry: 10/09/2018
- PACER
- Docket updated daily
3
Plaintiffs
12
Defendants
2
Accused
Products
3
Patents-in-Suit
1,009
Days in
Litigation
-
Bayer Intellectual Property GmbH, et al v. Aurobindo Pharma Limited, et al DC CAFC
- 1:15-cv-00902
- D. Del.
- Judge: Richard G. Andrews
- Filed: 10/09/2015
- Closed: 07/13/2018
- Latest Docket Entry: 10/09/2018
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Aurobindo Pharma Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg rivaroxaban tablets15 mg rivaroxaban tablets20 mg rivaroxaban tablets | US 7,157,456 B2 |
16
|
Infringement
Entry 328
|
Aurobindo Pharma USA Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg rivaroxaban tablets15 mg rivaroxaban tablets20 mg rivaroxaban tablets | US 7,157,456 B2 |
16
|
Infringement
Entry 328
|
Breckenridge Pharmaceutical, Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg rivaroxaban tablets15 mg rivaroxaban tablets20 mg oral rivaroxaban tablets | US 7,157,456 B2 |
16
|
Infringement
Entry 327
|
Invagen Pharmaceuticals Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg, 15 mg, 20 mg rivaroxaban tablets | US 7,157,456 B2 |
16
|
Infringement
Entry 330
|
Micro Labs Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg rivaroxaban tablets15 mg rivaroxaban tablets20 mg rivaroxaban tablets | US 7,157,456 B2 |
16
|
Infringement
Entry 326
|
Micro Labs USA Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg rivaroxaban tablets15 mg rivaroxaban tablets20 mg rivaroxaban tablets | US 7,157,456 B2 |
16
|
Infringement
Entry 326
|
Mylan Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg oral rivaroxaban tablets, 15 mg oral rivaroxaban tablets, 20 mg oral rivaroxaban tablets 10 mg rivaroxaban tablets, 15 mg rivaroxaban tablets, 20 mg rivaroxaban tablets | US 7,157,456 B2 |
16
|
Infringement
Entry 318
|
Mylan Pharmaceuticals Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg oral rivaroxaban tablets, 15 mg oral rivaroxaban tablets, 20 mg oral rivaroxaban tablets 10 mg rivaroxaban tablets, 15 mg rivaroxaban tablets, 20 mg rivaroxaban tablets | US 7,157,456 B2 |
16
|
Infringement
Entry 318
|
Prinston Pharmaceutical Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg, oral rivaroxaban tablets15 mg, oral rivaroxaban tablets20 mgoral rivaroxaban tablets 10 mgoral rivaroxaban tablets in 15 mgoral rivaroxaban tablets in 20 mg rivaroxaban tablets | US 7,157,456 B2 |
16
|
Infringement
Entry 329
|
Sigmapharm Laboratories LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg oral rivaroxaban tablets, 15 mg oral rivaroxaban tablets, 20 mg oral rivaroxaban tablets 10 mg rivaroxaban tablets, 15 mg rivaroxaban tablets, 20 mg rivaroxaban tablets | US 7,157,456 B2 |
16
|
Infringement
Entry 318
|
Torrent Pharmaceuticals Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg, oral rivaroxaban tablets15 mg, oral rivaroxaban tablets20 mg oral rivaroxaban tablets | US 7,157,456 B2 |
16
|
Infringement
Entry 334
|
Torrent Pharma Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg, oral rivaroxaban tablets15 mg, oral rivaroxaban tablets20 mg oral rivaroxaban tablets | US 7,157,456 B2 |
16
|
Infringement
Entry 334
|
